| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT06236269 | HR+/HER2- Advanced or Metastatic Breast Cancer Patients Treated With Sacituzumab Govitecan | Breast Cancer Stage IV | Recruiting |
| NCT07371585 | Trastuzumab Deruxtecan in First-Line HER2-Positive Metastatic Breast Cancer With… | Breast Cancer Stage IV | Recruiting |
| NCT05982093 | Elacestrant With/Without Triptorelin in Premenopausal Women With Luminal Breast Cancer | Breast Cancer | Recruiting |
| NCT05569811 | NeoadjuVAnt muLti-agENT Chemotherapy or Patritumab Deruxtecan With or Without endocrINE… | Breast Cancer | Active, Not Recruiting |
| NCT04802876 | Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with… | MSI-H Colorectal Cancer | Active, Not Recruiting |
| NCT04759248 | Study With Atezolizumab in Combination With Trastuzumab and Vinorelbine in HER2-positive… | Breast Cancer | Active, Not Recruiting |
| NCT05296746 | Neoadjuvant and Adjuvant Ribociclib and ET for Clinically High-risk ER+ and HER2- Breast… | Breast Cancer Stage II | Active, Not Recruiting |
| Not specified | |||
| NCT06991946 | Patient-Centric Study to Assess the Impact of Genomic Profiling on the Treatment of… | Metastatic Breast Cancer | Recruiting |
| NCT05885009 | Feasibility and Impact of Liquid Biopsy Genomic Profiling on Treatment Patients With… | Metastatic Prostate Cancer | Recruiting |
| NCT04497285 | Real World Study Using Comprehensive Genomic Data on the Next Treatment Decision Making… | Metastatic Breast Cancer | Active, Not Recruiting |
| NCT04257162 | HER2-PREDICT: Translational Study of Tumor Samples From Patients Treated With Trastuzumab… | Metastatic Cancer | Active, Not Recruiting |